us en false false Default
Skip directly to Accessibility Notice
PPH VanEck Pharmaceutical ETF Please read important disclosure Close important disclosure false

PPH
VanEck Pharmaceutical ETF

PPH
VanEck Pharmaceutical ETF

  • NAV
    $108.11

    as of February 02, 2026
  • YTD RETURNS
    4.84%

    as of February 02, 2026
  • Total Net Assets
    $1.17B

    as of February 02, 2026
  • Total Expense Ratio
    0.36%
  • Inception Date
    12/20/2011

About PPH

VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Buy Now
Let's Connect
Subscribe

Overview

Why PPH

  • Highly Liquid Companies: Tracks the largest most liquid pharmaceutical companies
  • Industry Leaders: Favors established industry leaders with meaningful scale
  • Global Scope: Provides exposure to U.S. and international equities for global industry representation  

Performance

Performance History:

Average Annual Total Returns* (%)

View All ETFs View All Indices
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 0.86 14.97 21.92 21.92 12.11 11.34 6.74 10.00
PPH (Share Price) 0.95 15.00 22.03 22.03 12.14 11.34 6.73 10.08
MVPPHTR (Index) 0.89 15.01 21.58 21.58 11.64 10.88 6.49 9.81
Performance Differential (NAV - Index) -0.03 -0.04 0.34 0.34 0.47 0.46 0.25 0.19
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 0.86 14.97 21.92 21.92 12.11 11.34 6.74 10.00
PPH (Share Price) 0.95 15.00 22.03 22.03 12.14 11.34 6.73 10.08
MVPPHTR (Index) 0.89 15.01 21.58 21.58 11.64 10.88 6.49 9.81
Performance Differential (NAV - Index) -0.03 -0.04 0.34 0.34 0.47 0.46 0.25 0.19

*Returns less than one year are not annualized.

The performance data quoted represents past performance. Past performance is not a guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Please call 800.826.2333 or visit vaneck.com for performance current to the most recent month ended.

Prices as of 02/02/2026

NAV/
Market
Price 		Volume
30-Day Avg./
Last Trading Day 		Daily Change
NAV/
Last Price 		YTD Change NAV/
Last Price 		Premium/
Discount 		30-Day
Median
Bid Ask
Spread 		NAV
Chart
PPH $108.11
$108.13 		417,996
708,340 		$1.33 / +1.25%
$1.32 / +1.24% 		+4.84%
+4.81% 		$0.02
0.02% 		0.03%

Fees

Holdings

Daily Holdings (%) as of 01/30/2026

Download XLS Get holdings
Total Holdings: 28
Ticker
 Holding Name % of Net
Assets
Identifier (FIGI)
Shares
 Asset Class Market Value
(US$) 		Notional Value
LLY US
 Eli Lilly & Co 19.38
BBG000BNBDC2
216,201
 Stock 224,232,867 --
NVS US
 Novartis Ag 10.46
BBG000LYF3S8
814,062
 Stock 121,034,738 --
MRK US
 Merck & Co Inc 9.00
BBG000BPD168
944,968
 Stock 104,201,621 --
NVO US
 Novo Nordisk A/S 7.28
BBG000BQBKR3
1,416,631
 Stock 84,190,380 --
PFE US
 Pfizer Inc 4.76
BBG000BR2B91
2,083,244
 Stock 55,080,971 --
JNJ US
 Johnson & Johnson 4.60
BBG000BMHYD1
234,024
 Stock 53,181,954 --
BMY US
 Bristol-Myers Squibb Co 4.49
BBG000DQLV23
943,869
 Stock 51,959,988 --
GSK US
 Gsk Plc 4.45
BBG000BLB481
998,459
 Stock 51,520,484 --
MCK US
 Mckesson Corp 4.27
BBG000DYGNW7
59,445
 Stock 49,411,278 --
AZNCF US
 Astrazeneca Plc 4.23
--
264,015
 Stock 48,985,343 --
AZN US
 Astrazeneca Plc 4.23
BBG000BZ0DK8
264,015
 Stock 48,985,343 --
--
Other 4.23
--
528,030
 other 48,985,343 --
ABBV US
 Abbvie Inc 4.14
BBG0025Y4RY4
214,654
 Stock 47,869,989 --
COR US
 Cencora Inc 4.07
BBG000MDCQC2
131,179
 Stock 47,122,120 --
SNY US
 Sanofi Sa/France 4.07
BBG000BBD5N1
1,001,564
 Stock 47,113,571 --
ZTS US
 Zoetis Inc 3.34
BBG0039320N9
309,309
 Stock 38,607,949 --
HLN US
 Haleon Plc 3.00
BBG018GZNCH6
3,316,181
 Stock 34,720,415 --
TAK US
 Takeda Pharmaceutical Co Ltd 2.76
BBG000LF8708
1,852,030
 Stock 31,910,477 --
TEVA US
 Teva Pharmaceutical Industries Ltd 2.75
BBG000C0CD58
932,543
 Stock 31,781,065 --
VTRS US
 Viatris Inc 0.76
BBG00Y4RQNH4
670,375
 Stock 8,775,209 --
JAZZ US
 Jazz Pharmaceuticals Plc 0.59
BBG000G9CGL0
41,610
 Stock 6,844,429 --
AXSM US
 Axsome Therapeutics Inc 0.48
BBG00B6G7GL7
30,204
 Stock 5,565,087 --
ELAN US
 Elanco Animal Health Inc 0.44
BBG00LJYS1P8
212,643
 Stock 5,120,443 --
CORT US
 Corcept Therapeutics Inc 0.19
BBG000BKJG33
54,921
 Stock 2,189,700 --
OGN US
 Organon & Co 0.12
BBG00ZQRGW24
169,122
 Stock 1,444,302 --
BHC US
 Bausch Health Cos Inc 0.09
BBG000DLFM21
177,759
 Stock 1,020,337 --
PRGO US
 Perrigo Co Plc 0.08
BBG000CNFQW6
68,322
 Stock 970,856 --
-USD CASH-
 0.06
--
689,404
 Cash Bal 689,404 --
--
Other/Cash -8.32
--
0
 Cash -96,292,881 --
← Scroll for more information →
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Portfolio

Sector Weightings (%) as at 12/31/2025

  • Sector

    % of Net Assets

  • Health Care

    99.93

  • Other/Cash

    0.07

Country Weightings (%) as at 12/31/2025

  • Country

    % of Net Assets

  • United States

    62.19

  • United Kingdom

    11.72

  • Switzerland

    10.04

  • Denmark

    6.45

  • France

    4.34

  • Israel

    2.60

  • Japan

    2.58

  • Other/Cash

    0.07

Distributions

Yields  as of  02/02/2026

Distribution Frequency

Quarterly

30-Day SEC Yield

1.87%

Distribution Yield

1.15%

12 Month Yield

1.70%

Yield information reflects temporary waivers of expenses and/or fees. Yields would have been reduced had these fees/expenses been included. In the absence of temporary expense waivers or reimbursements, the 30-Day SEC Yield for VanEck Pharmaceutical ETF would have been 1.87% on 02/02/26. Distributions may vary from time to time.

Team

Literature

PPH